Phase
Condition
Periodontitis
Treatment
dental implant placement and immediate provisionalization
Clinical Study ID
Ages 20-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female, between 20-80 years of age, who request dental implant treatmentoptions to replace missing teeth as part of comprehensive dental care
Subjects are willing to sign an informed consent, participate, and return forfollow-up visits.
Subjects without significant medical history and currently not on medications thatmight complicate the results
Exclusion
Exclusion Criteria:
Subjects who do not meet all the inclusion criteria or will not cooperate with theprotocol schedule.
Subjects who received and failed a previously placed dental implant.
Subjects who require a bone and soft tissue grafting procedure prior to or at thetime of the implant placement.
Subjects with significant untreated periodontal disease, caries, infection, orchronic inflammation in the oral cavity within two adjacent tooth positions of theclinical trial area.
Subjects who have used nicotine-containing products within three weeks prior tosurgery.
Subjects who are insulin-dependent diabetic or if their Hgb1c levels > 6.5%.
Subjects with a history of malignancy within the past five years (except for basalor squamous cell carcinoma of the skin or in situ cervical carcinoma).
Subjects who are nursing or pregnant.
Subjects who are presently taking medications (except estrogen/progesterone therapy)or those who are undergoing treatment that is known to affect bone turnover.
Subjects with diseases affecting bone metabolism (excluding idiopathicosteoporosis).
Subjects with a history of an autoimmune disease, documented allergy or multipleallergies to any component of the agents used in this study.
Acutely infected defect site.
Study Design
Study Description
Connect with a study center
Harvard Dental Center
Boston, Massachusetts 02115
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.